Dysosteosclerosis

Dysosteosclerosis is an extremely rare inherited skeletal disorder classified among the sclerosing bone dysplasias. It is characterized by progressive osteosclerosis (abnormal hardening and increased density of bone), particularly affecting the skull base and long bones, combined with platyspondyly (flattened vertebral bodies). The condition affects multiple body systems, with the skeletal system being most prominently involved. Key clinical features include short stature, pathologic fractures due to abnormally brittle yet dense bones, cranial nerve compression (which can lead to optic atrophy and visual impairment, as well as hearing loss), and dental abnormalities including delayed tooth eruption and enamel defects. Some patients also exhibit skin manifestations such as areas of red, violaceous (reddish-purple) skin lesions. The disease typically presents in early childhood with progressive skeletal changes. Radiographic findings are distinctive and include diffuse osteosclerosis of the skull base, sclerosis of the long bones with metaphyseal lucencies (radiolucent areas near the ends of long bones), and platyspondyly. Bone marrow failure may occur as the medullary cavities become obliterated by abnormally dense bone, potentially leading to anemia and other hematologic complications. Neurological complications arise primarily from narrowing of cranial foramina due to progressive bone thickening. There is currently no cure or disease-specific treatment for dysosteosclerosis. Management is supportive and multidisciplinary, focusing on monitoring and treating complications such as fractures, visual and hearing impairment, and hematologic abnormalities. Hematopoietic stem cell transplantation has been considered in cases with significant bone marrow involvement, similar to approaches used in other sclerosing bone disorders like osteopetrosis. Genetic counseling is recommended for affected families. Mutations in the SLC29A3 gene and the TNFRSF11A gene have been identified in some cases, linking the condition to impaired osteoclast function.

Common questions about Dysosteosclerosis